Vocal fo ld inj ection with botulinum toxin type A (BTX-A) may be used as an adjunct treatment for habit cough in children. We conducted a retrospective review of3 cases involving children aged 11 to l 3 years with habit cough treated with vocal fo ld injection of BTX-A. Injections of BTX-A to the thyroarytenoid muscles were effective in breaking the cough cycle in all 3 children. Their coughs recurred but were controlled with 4 to 8 sessions of behavioral therapy. Behavioral therapy remains the firstline treatment, but BTX-A may be a useful complement to behavioral therapy in patients who fail standard treatments or in those with severe cough who have limited or delayed access to mental health professionals. This is the fi rst report, to our knowledge, on the use of BTX-A in the treatment ofa habit cough.
Introduction
Habit, or psych ogeni c, cough is a somatofor m disorder that occ urs in older children and adolescents. It presents as a stereotypic, non productive cough for which there is no underlying medi cal explanation. Often described as "ho nking" or "seal-like ," it can occ ur up to several hundred times an hour dur ing waki ng hours; it is characteristically absent during sleep.J The patient history may reveal the rece nt introd uction of an unusually stress ful soc ial situation . Whi le the disorder is mild in some chi ldren, in others it is severe enoug h to cause them to miss several month s of school.
Habit cough is not belie ved to be overl y common in the gene ral pediatric popu lation. However, it was found to be the third most co mmon cause of chronic cough in children aged 6 to 16 years with normal chest x-rays who were referred to one tertiary pediatric otolaryngology practice. 2 The principal treatment for habit cough is behaviora l therapy, as well as addressing underlying psych iatric issues.' ?
We recent ly evaluated the cases of 3 chi ldren with habit cough in the pediatric air way and swallow ing disorders clini c at Massachusetts Eye and Ear Infirmary (MEEI). Each child had a debilitating cough that had resulted in prolo nged school absence .We found no identifiab le organic cause. We hypothesized that vocal fold injection with botu linum toxin type A (BTX-A) might break the coug h cycle. While waiting for the children's first appointment for psycho logical eva luation , we tried this trea tment in an attempt to impro ve their funct ion so that they co uld return to school sooner. We felt that if the treatment were successful, this would also make psychological eva luation and interve ntion eas ier.
Patients and methods
This study was approved by the institutional review board at ME El. Charts of patients were reviewe d from January 2004 throug h July 2006. Charts of 3 childre n with habit cough treate d with BT X-A were selec ted. We recorded det ails concerning how the diagnosis of habit cough was estab lished and the outcomes after BTX-A injec tion.
The 3 patients in our study had missed between 2 and 6 month s of school becau se of their incessant co ughing . Each patient was evaluated individually by a pediatric otolaryngologist, gastroentero logist, and pulmonologist during the initia l visit.
A frequent, dry cough causing embarrass ment and prolon ged school absence was the chief complaint of each patient and hisor her family. The cough was present durin g waking hours and absent during sleep. None of the patients had a history of fever, wheez ing, rhinorrhea, postnasal drip, hear tburn, choking, gasp ing for air, facia l pain , or fatigue . Eac h child had been hea lthy before the onset of the cough. Referrin g physicians had attempted empiric treatment s with antibiotics, H 2-antihi stamines ENT-Ear, Nose & Throat Journal >September 2007 or proton-pump inhibitors, and asthma inhalers in all 3 patients without success.
The physical exams were highlighted by a frequent, nonproductive cough with a honking or barking quality . No signs of respiratory distress or systemic illness were observed, and there was no stridor or wheezing. Verbal requests to control the cough were met with failure. Results of chest x-rays and pulmonary function tests were normal.
We told the parents that habit cough was the likely diagnosis and thatthe primary treatment was behavioral therapy. The patients were referred to a clinical child psychologist specializing in somatoform disorders. We also explained to the parents that to completely rule out an organic cause for their child's cough, direct laryngoscopy, rigid and flexible bronchoscopy, and gastroesophagoduodenoscopy could be performed under general anesthesia. If the endoscopic findings were normal, we could inject BTX -A into the patient's vocal folds . If this treatment proved successful, the cough cou ld be expected to resolve for as long as 2 to 3 months, allowing the patients to return to daily activities more quickly than with behavioral therapy alone. We informed the parents that this was an unproven, off-label use of BTX-A and that risks of dysphonia, aspiration, and tracheotomy were possible.
No abnormalities were seen on endoscopy in any of the 3 patients. We sent pathologic specimens of duodenal, gastric, and esophageal biopsies for examination, and they all proved to be normal. Five units of BTX-A (2.5 U/O. I ml normal saline) were injected into each of two locations on each thyroarytenoid muscle with a 25-gauge laryngeal injection needle at the time of direct laryngoscopy.
Results
All 3 patients had cessation of their coug h after the injections , and all 3 reported decreased irritation in their throats at post-treatment vis its.
Patient 1. This 12-year-old boy had presented with a 3month history of incessant cough; he had missed 2 months of school. After he received a laryngeal BTX-A injection, his cough resolved immediately. The boy was of Korean ancestry and had Caucasian adop tive parents. His parents were asked specific questions about his adoption, which had taken place just prior to the onset of his cough. He did not keep his follow -up appointments at MEEI until after his coug h returned 2.5 months postinjection. Behavioral therapy (4 sessions) was instit uted, and an additional referral was made to a psychologist who specializes in treating chi ldren with adoption issues . He rema ins asymptomatic 10 months post -treatment.
Patient 2. A lO-year-old girl presented with 3 months of school absence due to a chronic cough. The cough would disappear when the patient was in the supine position . She was brought into the clinic on a stretcher. After Volume 86, Number 9 the application of nebulized lidocaine, she was able to sit upright without coughing for I hour. Her cough resolved on the second day after she received the BTX-A injection . Behavioral therapy was initiated, during which it was revealed that her cough had started after her father moved to a different state. This issue was addressed by the psychologist. Now, 9 months after injection, there have been 2 evenings during which her cough has recurred, the first of which was 6 months after treatment. However, each time it reso lved after the mother firmly told her tha t the cough had no medical cause.
Patients, This 13-year-old girl was originally referred for the eva luation of a "post-pertussis tic." She had been treated for a chronic dry coug h that began after she had received two separate courses of azithromycin for a high pertussis titer. Her initial cough had resolved, but a second cough began after a live singing performance. It lasted for more than 6 months, did not respond to a host of medical treatment regimens, and was significantly affecting her quality of life. Her cough reso lved on the second post-treatment day but returned after 10 days. On further questioning, it was learned that the patient's family had recently assumed care of two male foster children j ust before the return of the cough. Behavioral therapy was instit uted, and the patient was able to keep her coug h under control.
Discussion
Habit cough caused significant social disruption for our 3 patients and their families .All 3 patients stopped coughing after BTX-Ainjections and quickly returned to school. All of the patients reported being better able to suppress their urges to coug h after injection. However, each patient had recurrences of the cough that reso lved only after behavioral intervention .
Factors at the receptor, afferent, cortical, and efferent level contribute to the seemingly simple comp laint of a cough.v ' Psychologica l factors and habituation in conjunction with physical irritants have been proposed as other mechanisms."The patients in our cases series reported that irritation had triggered their coughs; the irritation disappeared with the administration of topical lidocaine in one of our patients. We hypothesized that laryngeal BTX-A injections could break the cough cycle in children with habit cough.
Pertussis is a common cause of chronic coug h in adolescents and young adults .The initial catarrhal phase resembles an upper respiratory infection lasting I to 2 weeks. This is followed by paroxysmal coughing spells that last another I to 2 weeks. The convalescent stage is characterized by a residual cough that lasts weeks to months."Harnden et al reported that persistent cough was present 100 days after the serologic diagnosis of pert ussis in 40 of 62 children .'? Serology studies are most useful late in the course of disease, and evaluation of pertussis in children with a www.entjournal.com • 57 1 S IPP. HAVER, MAS EK, HARTNI CK long-standing co urse should be considered." We chose not to test the children in this series for pertussis for several reasons: First, each child in this series prese nted with a barking or "seal-like" cough that was abse nt during sleep, which is stereotypic of habit cough. Also, each child had exper ienced the introduction or magnification of a significant psychosoc ial stressor during the onset of the cough. Habit, or psychogenic, cough is a clinical diagnosis, and it is very commo n for habit cough to appear after a respiratory illness.':":" Finally, there is also little to no effect on the course of per tussis if treatment is delayed 1 week after onset of symptoms. 10 While the outcomes of these cases were satisfactory, sound scie ntific concl usions about the effec tiveness of BTX-A in treating habit cough cannot be made . One patient had comp lete resolution of his cough immediately after injection with BTX-A-well before its phar macolog ic activity is known to take effect. Kravitz et al reported that resolution of habi t cough occurred after the simple suggest ion that the patie nt undergo bronchoscopy.13
The effect iveness of treati ng habit coug h with noninvasive techniques is discussed in 9 separate reports. 1. 3-5. 11-15 In these reports , 95% of patients (1111117) with habit cough were succes sfully treated with reassurance in conj unction with various forms of hyp notic, behavioral, psych iatric, or speec h therapy. Some of these patients were reported to experience a comp lete cure after one intervention.
Given the success of nonpharmacologic treatments, firstline intervention should be behavioral therapy performed by professionals fami liar with behavioral medicine interventions. Laryngeal BTX-A injections could be considered for recalci trant cases of habit cough in whic h a mental health professional feels it might be advantageo us to lessen the symp toms as a com ponen t of a behavioral intervention.
Laryngeal BTX -A injec tions may playa role (I) in patients with habit coug h in whom standard treatments fail, (2) as an adjunct to behavioral therapy, or (3) in patients with severe cough who have delayed or limite d access to mental health professionals. Th is is the first report , to our knowledge, discussing the use of BTX-A in the treatment of a habit cough.
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